LGALS3 and coronary artery disorder: Given the evolving role of galectin-3 and pentraxin-3 in cardiovascular pathophysiology—especially their associations with myocardial fibrosis, vascular inflammation, and prognosis in CAD—the lack of serial measurements represents a missed opportunity for a more nuanced analysis.